Evidence map›Paper›PMID 40386632›Full record

Article3 Biotech2025

Quantification of

Nagamani Sandra, Ankita Tripathi, Sanjay Kumar Lal, Harsh Kumar Dikshit

Abstract read
In one paragraph

Article in 3 Biotech, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nagamani SandraSeed Pathology Laboratory, Division of Seed Science and Technology, ICAR-Indian Agricultural Research Institute, New Delhi, 110012 India.ORCID 0000-0001-9253-7515
Ankita TripathiSeed Pathology Laboratory, Division of Seed Science and Technology, ICAR-Indian Agricultural Research Institute, New Delhi, 110012 India.
Sanjay Kumar LalDivision of Genetics, ICAR-Indian Agricultural Research Institute, New Delhi, 110012 India.
Harsh Kumar DikshitDivision of Genetics, ICAR-Indian Agricultural Research Institute, New Delhi, 110012 India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Soybean yellow mottle mosaic virus (SYMMV) is a newly emerging seed borne plant virus responsible for mosaic and mottling disease in mungbean and soybean. The present study aimed to evaluate the response of nine widely cultivated mungbean and 15 newly developed soybean genotypes to SYMMV-Mb infection under controlled environment conditions using agro-inoculation, followed by serological and molecular detection. The genotypes exhibited differential local symptoms at 13-17 dpi and systemic symptoms at 21-29 days post-inoculation (dpi), ranging from mild chlorosis to severe necrotic local spots with a PDI of 60-95% in mungbean and 30-50% in soybean genotypes. Among the mungbean genotypes, Sona Moong was found to be moderately susceptible (MS), six were susceptible and Pusa Vishal and SML-668 were highly susceptible. Among the soybean genotypes, nine were found to be immune, four were moderately resistant and two were MS. DAC-ELISA and RT-PCR confirmed the presence of SYMMV-Mb in all infected genotypes with higher absorbance values and amplification of the 1064 bp coat protein (CP) region. RT-qPCR analysis of whole seeds harvested from agro-inoculated plants revealed virus accumulation only in mungbean genotypes ranging from 6.33 × 10 Supplementary Information: The online version contains supplementary material available at 10.1007/s13205-025-04347-w.

Indexed as

DAC-ELISAMungbeanPCRSoybeanSoybean yellow mottle mosaic virus

Identifiers

PMID40386632
PMCPMC12084199

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.